Clinical Trial Update: Evaluation of Contrast-enhanced Ultrasound Imaging for the Early Estimate of Bevacizumab Effect on Colorectal Cancer Liver Metastases [NA]

View source ↗

Summary

A completed clinical trial evaluated contrast-enhanced ultrasound imaging as an early indicator of bevacizumab effect on metastatic colorectal cancer with liver…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: University Hospital, Tours | Conditions: Metastatic Colorectal Cancer | NA | Status: COMPLETED